Good morning
I guess that you already know this but its just a matter of
- reducing the dose
- waiting a few days before restesting
- deciding if a cycle back to step 1 is needed
just to perhaps reassure you the INR she's on is not a worringly high INR, for instance
shows that anything up to INR < 4.5 is not statistically more likely for bleeds
Basically the issue is to do with the enantiomers of warfarin. From MIMS on my specific warfarin brand (you'll find similar entries for Warfarin brand too):
Marevan is a racemic mixture of the R and S--enantiomers. The S--enantiomer exhibits two to five times more anticoagulant activity than the R--enantiomer in humans, but generally has a more rapid clearance.
then additional information from
this source:
During recent years it has been found that one of the possible enantiomers usually has a pharmacological profile that is superior to the racemate. Hence pharmaceutical companies have been replacing exisiting racemic drugs with their pure enantiomeric form.
In the case of Warfarin it was found that S-Warfarin is the superior enantiomer being 6 times more active than R-Warfarin. There are 2 main methods to form a pure enantiomeric form of Warfarin.
so as I say it depends on your brand what you may experience.
Reach out if you have any questions
Best Wishes